You just read:

Ardelyx Receives FDA Approval for IBSRELA® (Tenapanor), an NHE3 Sodium Transport Inhibitor, for the Treatment of Irritable Bowel Syndrome with Constipation

News provided by

Ardelyx

Sep 12, 2019, 15:13 ET